Increased use of multidisciplinary treatment modalities adds little to the outcome of rectal cancer treated by optimal total mesorectal excision.

Hdl Handle:
http://hdl.handle.net/10147/297916
Title:
Increased use of multidisciplinary treatment modalities adds little to the outcome of rectal cancer treated by optimal total mesorectal excision.
Authors:
Chang, Kah Hoong; Smith, Myles J; McAnena, Oliver J; Aprjanto, Arifin S; Dowdall, Joe F
Affiliation:
Department of Surgery, Galway University Hospital, National University of Ireland, Galway, Republic of Ireland.
Citation:
Increased use of multidisciplinary treatment modalities adds little to the outcome of rectal cancer treated by optimal total mesorectal excision. 2012, 27 (10):1275-83 Int J Colorectal Dis
Journal:
International journal of colorectal disease
Issue Date:
Oct-2012
URI:
http://hdl.handle.net/10147/297916
DOI:
10.1007/s00384-012-1440-8
PubMed ID:
22395659
Abstract:
Total mesorectal excision (TME) is the standard surgical treatment for rectal cancer. The roles of chemotherapy and radiotherapy have become more defined, accompanied by improvements in preoperative staging and histopathological assessment. We analyse our ongoing results in the light of changing patterns of treatment over consecutive time periods.
Item Type:
Article
Language:
en
MeSH:
Adult; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Rectal Neoplasms; Rectum; Treatment Outcome
ISSN:
1432-1262

Full metadata record

DC FieldValue Language
dc.contributor.authorChang, Kah Hoongen_GB
dc.contributor.authorSmith, Myles Jen_GB
dc.contributor.authorMcAnena, Oliver Jen_GB
dc.contributor.authorAprjanto, Arifin Sen_GB
dc.contributor.authorDowdall, Joe Fen_GB
dc.date.accessioned2013-08-12T15:07:16Z-
dc.date.available2013-08-12T15:07:16Z-
dc.date.issued2012-10-
dc.identifier.citationIncreased use of multidisciplinary treatment modalities adds little to the outcome of rectal cancer treated by optimal total mesorectal excision. 2012, 27 (10):1275-83 Int J Colorectal Disen_GB
dc.identifier.issn1432-1262-
dc.identifier.pmid22395659-
dc.identifier.doi10.1007/s00384-012-1440-8-
dc.identifier.urihttp://hdl.handle.net/10147/297916-
dc.description.abstractTotal mesorectal excision (TME) is the standard surgical treatment for rectal cancer. The roles of chemotherapy and radiotherapy have become more defined, accompanied by improvements in preoperative staging and histopathological assessment. We analyse our ongoing results in the light of changing patterns of treatment over consecutive time periods.en_GB
dc.language.isoenen
dc.rightsArchived with thanks to International journal of colorectal diseaseen_GB
dc.subject.meshAdult-
dc.subject.meshCombined Modality Therapy-
dc.subject.meshDisease-Free Survival-
dc.subject.meshFemale-
dc.subject.meshHumans-
dc.subject.meshKaplan-Meier Estimate-
dc.subject.meshMale-
dc.subject.meshMiddle Aged-
dc.subject.meshNeoplasm Recurrence, Local-
dc.subject.meshRectal Neoplasms-
dc.subject.meshRectum-
dc.subject.meshTreatment Outcome-
dc.titleIncreased use of multidisciplinary treatment modalities adds little to the outcome of rectal cancer treated by optimal total mesorectal excision.en_GB
dc.typeArticleen
dc.contributor.departmentDepartment of Surgery, Galway University Hospital, National University of Ireland, Galway, Republic of Ireland.en_GB
dc.identifier.journalInternational journal of colorectal diseaseen_GB
dc.description.fundingNo fundingen
dc.description.provinceConnachten
dc.description.peer-reviewpeer-reviewen

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.